07:00 , Mar 26, 2012 |  BioCentury  |  Emerging Company Profile

BioMetrx: RASS restoration

BioMetrx LLC has early data for its Rasstore suggesting that restoring levels of the tumor suppressor gene RASSF1A may lead to superior safety and efficacy compared to current prostate cancer therapies. Rasstore selectively inhibits an...
08:00 , Jan 30, 2012 |  BC Week In Review  |  Company News

BioMetrx, Georgetown University deal

Georgetown University Medical Center granted newco BioMetrx exclusive, worldwide rights to cancer product Rasstore. Rasstore is a fluorescent carbazole analog of mahanine, which increases mRNA expression of the tumor suppressor gene Ras association domain family...
00:28 , Jan 25, 2012 |  BC Extra  |  Company News

Newco BioMetrx licenses RASSF1A product

Georgetown University Medical Center granted newco BioMetrx LLC (Bethesda, Md.) exclusive, worldwide rights to cancer product Rasstore. Rasstore is a fluorescent carbazole analog of mahanine, which increases mRNA expression of the tumor suppressor gene Ras...